Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Biopurify Phytochemicals, also frequently cited in academic literature as Chengdu Preferred Biological Technology, is a high-tech enterprise specializing in the research, production, and global distribution of high-purity phytochemicals and reference standards. The company maintains an extensive library of over 3,000 natural product components derived from Traditional Chinese Medicine (TCM), serving as a critical supplier for major international pharmacopoeias including the USP and EDQM. Beyond catalog products, Biopurify offers specialized contract research and manufacturing services, including custom extraction, purification, and semi-synthesis of active pharmaceutical ingredients. Their high-quality compounds are widely utilized by global pharmaceutical leaders and research institutions for drug screening and quality control across therapeutic areas such as oncology, neurology, and metabolic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Preferred Biological Technology.